United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
NEW YORK, Jan. 29, 2014 /PRNewswire/ — Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare, a division of UnitedHealth Group (NYSE:UNH), to provide the pathology analysis for these specialty services.
Under the agreement, Therapath will work directly with the United Healthcare physician network to handle and process the pathology specimens at a fraction of the cost of non-participating pathology laboratories. In addition, the transaction will improve the turn-around time of results for both the patients and physicians.
Therapath Neuropathology, founded in 2004, is a College of American Pathology (CAP) accredited laboratory that provides pathology services throughout the United States. It currently serves clients (medical centers and physicians) from every state in the US. Physicians in United Healthcare’s network can submit their specimens directly to Therapath.
“Therapath’s partnership with United Healthcare will provide a (better) high quality, reliable and more convenient experience for United Healthcare physicians and members at a lower cost than traditional non specialized labs,” said Charles (Chip) Hearn, Director of Finance at Therapath. “Our process ensures a simplified, consistent process to submit these specialized biopsy specimens which will benefit both the physicians and UNH members.”
About Therapath Neuropathology:
Therapath LLC, is privately held and offers its specialized neuromuscular pathology services to academic institutions, research organizations, and pharmaceutical companies, for both clinical and pre-clinical investigations of potential therapeutic agents, toxicity, or regeneration studies. Therapath provides complete testing of Muscle Biopsy; Nerve Biopsy; skin biopsy for Small Fiber Neuropathy: Epidermal Nerve Fiber Density (ENFD) and Sweat Gland Nerve Fiber Density (SGNFD); and skin biopsy for neurological disease with Electron Microscopy. Therapath provides consultations for brain, spinal cord tumor biopsy, and resection specimens; non-neoplastic brain and spinal cord biopsy specimens; and brain and spinal cord autopsy specimens, including dementias.
Therapath is headquartered in New York, NY. Visit Therapath online at www.therapath.com
Contact:
Therapath Neuropathology
Geoff Whitehouse, 800-681-4338
gwhitehouse@therapath.com
Related Articles
Research Finds Nerve Damage in Patients with Fibromyalgia
Becky Tsai2022-09-05T17:50:29-05:00
Therapath, LLC reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. [Read More]
Quality of Life and Usefulness of Skin Biopsy in Small Fiber Neuropathy (SFN)
Becky Tsai2022-09-05T17:51:25-05:00
Bakkers et al examined a total of 265 patients diagnosed with small fiber neuropathy (SFN). They found that SFN was associated with a severe impairment in Quality of Life...[Read More]
New Upper Extremity Standard Biopsy Sites for Diagnosis of Small Fiber Neuropathy
Becky Tsai2022-09-05T17:52:41-05:00
Therapath LLC has established normative values for two upper limb body sites that can now be used to evaluate 3mm punch skin biopsy specimens...[Read More]
United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
Becky Tsai2022-09-05T17:54:35-05:00
Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare...[Read More]
United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
NEW YORK, Jan. 29, 2014 /PRNewswire/ — Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare, a division of UnitedHealth Group (NYSE:UNH), to provide the pathology analysis for these specialty services.
Under the agreement, Therapath will work directly with the United Healthcare physician network to handle and process the pathology specimens at a fraction of the cost of non-participating pathology laboratories. In addition, the transaction will improve the turn-around time of results for both the patients and physicians.
Therapath Neuropathology, founded in 2004, is a College of American Pathology (CAP) accredited laboratory that provides pathology services throughout the United States. It currently serves clients (medical centers and physicians) from every state in the US. Physicians in United Healthcare’s network can submit their specimens directly to Therapath.
“Therapath’s partnership with United Healthcare will provide a (better) high quality, reliable and more convenient experience for United Healthcare physicians and members at a lower cost than traditional non specialized labs,” said Charles (Chip) Hearn, Director of Finance at Therapath. “Our process ensures a simplified, consistent process to submit these specialized biopsy specimens which will benefit both the physicians and UNH members.”
About Therapath Neuropathology:
Therapath LLC, is privately held and offers its specialized neuromuscular pathology services to academic institutions, research organizations, and pharmaceutical companies, for both clinical and pre-clinical investigations of potential therapeutic agents, toxicity, or regeneration studies. Therapath provides complete testing of Muscle Biopsy; Nerve Biopsy; skin biopsy for Small Fiber Neuropathy: Epidermal Nerve Fiber Density (ENFD) and Sweat Gland Nerve Fiber Density (SGNFD); and skin biopsy for neurological disease with Electron Microscopy. Therapath provides consultations for brain, spinal cord tumor biopsy, and resection specimens; non-neoplastic brain and spinal cord biopsy specimens; and brain and spinal cord autopsy specimens, including dementias.
Therapath is headquartered in New York, NY. Visit Therapath online at www.therapath.com
Contact:
Therapath Neuropathology
Geoff Whitehouse, 800-681-4338
gwhitehouse@therapath.com
Related Articles
Research Finds Nerve Damage in Patients with Fibromyalgia
Becky Tsai2022-09-05T17:50:29-05:00
Therapath, LLC reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. [Read More]
Quality of Life and Usefulness of Skin Biopsy in Small Fiber Neuropathy (SFN)
Becky Tsai2022-09-05T17:51:25-05:00
Bakkers et al examined a total of 265 patients diagnosed with small fiber neuropathy (SFN). They found that SFN was associated with a severe impairment in Quality of Life...[Read More]
New Upper Extremity Standard Biopsy Sites for Diagnosis of Small Fiber Neuropathy
Becky Tsai2022-09-05T17:52:41-05:00
Therapath LLC has established normative values for two upper limb body sites that can now be used to evaluate 3mm punch skin biopsy specimens...[Read More]
United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
Becky Tsai2022-09-05T17:54:35-05:00
Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare...[Read More]
